The Yardstick That Matters: Redefining Outcomes in Prescription Care

Outcomes don’t improve by accident. Better processes, faster therapy access, and clear guidance are the foundation of patient-centered prescription care—and the new standard employers should expect.

Formulary design that captures the savings (without disruption)

Rebates don’t equal value. Here’s how to align to net cost, enable substitution, and keep your people on track.

Biosimilars: What HR Leaders Need to Know in 5 Minutes

If we had five minutes between meetings, here’s what I’d share: biosimilars are no longer a maybe. They’re a practical way to protect your budget and keep care steady for your people.

GLP-1s in 2026: Fund Access, Protect Outcomes, Avoid the Blank Check

If you manage employer benefits, you’re staring at a 2026 puzzle: demand for GLP-1 medications keeps climbing while prices remain elevated, and oral options may expand utilization further.

The Silent Surge Driving Pharmacy Costs — and How to Stop It

Right now, there’s a storm brewing in specialty drug trend—and most plan sponsors don’t even see it coming. If you’re focused

How to Switch PBMs Without Disruption

Switching pharmacy benefit partners can feel risky—especially for employers who’ve experienced disruption in the past. But it doesn’t have to be that hard.

You Shouldn’t Need a Law Degree to Understand Your PBM Contract

Pharmacy benefit contracts are full of fine print—and what’s buried in the language can shape everything from how much you pay to what your employees can access.